Key result
A 56-year-old male patient developed recurrent metastatic cardiac rhabdomyosarcoma 10 months after surgical resection and died on the fifth day after diagnosis due to multiorgan failure.
Why the study?
Cardiac rhabdomyosarcoma is an aggressive malignant tumor with frequent recurrence and high mortality despite surgical resection, radiotherapy, and chemotherapy.
Case Report (n=1)
This case highlights the aggressive nature and high recurrence rate of cardiac rhabdomyosarcoma despite surgical intervention.
May warrant close surveillance after cardiac rhabdomyosarcoma surgery; leaves open optimal adjuvant strategies.
Rhabdomyosarcoma, which accounts for 20% of all malignant tumors of the heart, is an aggressive tumor originating in the ventricular wall. These tumors are the second most common malignant primary tumor of the heart after angiosarcoma. Despite treatment options, such as surgical resection, radiotherapy, and chemotherapy, recurrence is common and mortality is high. Among these patients, survival with surgical resection is around six months to one year. In this case report, we discuss a patient who presented with recurrent rhabdomyosarcoma with distant metastasis after surgical intervention. A 56-year-old male patient who underwent left atrial mass excision and mitral valve replacement ten months prior was admitted with recurrent metastatic rhabdomyosarcoma.
No takes yet. Share an insight, caveat, or question.
Reyhanoğlu et al. (2022) conducted a case report in Recurrent cardiac rhabdomyosarcoma (n=1). Surgical resection (left atrial mass excision and mitral valve replacement) was evaluated on Tumor recurrence and survival. A 56-year-old male patient developed recurrent metastatic cardiac rhabdomyosarcoma 10 months after surgical resection and died on the fifth day after diagnosis due to multiorgan failure.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: